Inflammatory bowel diseases. 2025 Jun 13:izaf119. doi: 10.1093/ibd/izaf119 Q14.32025
Safety and Effectiveness of QingDai (Indigo naturalis) in Children With Mild-to-Moderate Ulcerative Colitis: A Short-Term 6-Week Open-Label Trial
青黛治疗轻中度活动性溃疡性结肠炎儿童短期疗效及安全性观察:开放式临床试验研究 翻译改进
作者单位 +展开
作者单位
DOI: 10.1093/ibd/izaf119 PMID: 40512056
摘要 中英对照阅读
相关内容
-
Liquid Chromatography-Tandem Mass Spectrometry-Based Metabolomics Analysis of Indigo Naturalis Treatment of Ulcerative Colitis in Mice
基于液相色谱-串联质谱的代谢组学分析青黛治疗溃疡性结肠炎小鼠模型的作用机制
Journal of medicinal food. 2023 Dec;26(12):877-889.
-
Treatment-refractory ulcerative colitis responsive to indigo naturalis
难治性溃疡性结肠炎应用青黛治疗缓解
BMJ open gastroenterology. 2021 Dec;8(1):e000813.
-
Clinical outcomes of patients with remitting ulcerative colitis after discontinuation of indigo naturalis
使用青黛治疗后临床缓解的溃疡性结肠炎患者的停药结果
Scientific reports. 2024 Mar 9;14(1):5778.
-
Clinical efficacy and future application of indigo naturalis in the treatment of ulcerative colitis
青黛治疗溃疡性结肠炎的临床疗效及其未来应用展望
Journal of ethnopharmacology. 2025 Jan 30;337(Pt 1):118782.
-
Exploring the Mechanism of Indigo Naturalis in the Treatment of Ulcerative Colitis Based on TLR4/MyD88/NF-κB Signaling Pathway and Gut Microbiota
基于TLR4/MyD88/NF-κB信号通路及肠道菌群探讨青黛治疗溃疡性结肠炎的机制研究
Frontiers in pharmacology. 2021 Jul 22:12:674416.
-
Efficacy of Indigo Naturalis Therapy for Ulcerative Colitis: A Case Series
青黛治疗溃疡性结肠炎的疗效观察:系列病例报道
Internal medicine (Tokyo, Japan). 2019 Aug 15;58(16):2299-2304.
-
Ischemic colitis induced by indigo naturalis in a patient with ulcerative colitis: a case report
一例溃疡性结肠炎患者因青黛引起缺血性结肠炎的病例报告
BMC gastroenterology. 2020 May 15;20(1):154.
-
Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trial
关黄柏短期治疗溃疡性结肠炎的疗效及安全性研究:一项申办者发起的多中心双盲临床试验
PloS one. 2020 Nov 5;15(11):e0241337.